Navigation Links
Exubera could mean the end of an insulin injection era for diabetics

Diabetes and cancer remain the most feared diseases all around the world. Researchers have now come up with an insulin inhaler, potentially offering adult diabetics an alternative to injections// for controlling their blood sugar. The drug is yet to be approved by the FDA.

If approved, the drug, known as Exubera, would mean an end to the insulin injections taken by millions worldwide. The product works by releasing an insulin-powder cloud inhaled via a handheld plastic machine similar to the inhalers used for asthma and allergy. The drug has been in development for a decade and is now backed by a joint venture between Pfizer, Sanofi-Aventis and Nektar Therapeutics.

Pfizer presented several studies showing Exubera controlled blood sugar as well as insulin shots for up to two years in patients with both forms of diabetes. Questions remain about whether adult Type 1 diabetics can expect to achieve tight glycemic control with Exubera.

Up to two-thirds of all diabetics do not adequately control their blood sugar, according to the American Academy of Clinical Endocrinologists. Poor control over the long term can lead to blood vessel and organ damage, blindness, and kidney failure and foot ailments.

Despite approval, many would still have to use needles, because the drug is not a replacement for the currently available longer-acting insulin. In addition, patients who smoke will be excluded from taking the drug, because of evidence that damage from cigarettes boosts patients` exposure to insulin.

'To have people rush to the this product saying, `I can throw away my syringes` ... is simply an incorrect message and that needs to be emphasized more,' said Dr. Paul D. Woolf, chief of medicine at Crozer Chester Medical Center in Upland, Pa., and acting chair of the advisory panel. I think the use of insulin without a needle, the siren call of that is almost irresistible,' said Rebecca W. Killion, the panel`s patient representative --
'"/>




Page: 1 2

Related medicine news :

1. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
2. Exubera is effective in diabetes patients with cold or flu
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Exubera could mean the end insulin injection era for diabetics

(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Traveling to ... a wide array of magnificent flora and fauna. , Lifestyle Holidays Vacation ... well-preserved history. To help make travelers experience that much better, Lifestyle Holidays Vacation Club ...
(Date:9/1/2015)... Hills, CA (PRWEB) , ... September 01, 2015 ... ... International Business Times discusses the hundreds of thousands of plastic surgeries conducted each ... media and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam ...
(Date:9/1/2015)... ... , ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills ... year in the United States. , Prostate cancer is to men what breast cancer ... in 7 men. One new case occurs every 2.3 minutes and a man dies ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ has ... of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA ... demonstrating its safety when used at home to combat hair loss. , ...
Breaking Medicine News(10 mins):Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... staff members working in a hospital,s fast-paced emergency department ... involved in medication errors that harm patients, new Johns ... serious issues related to temporary nursing staff in particular ... of the health care workforce owing to the national ...
... SUNY Downstate Medical Center have received a $50,000 grant ... develop a diagnostic test for the folate receptor autoantibody. ... cerebral folate deficiency in infants and autism spectrum disorders. ... United States, neural tube defects result in the brain ...
... to make people "tear up," but a new study led by ... nasal spray containing an ingredient derived from hot chili peppers ( ... sinus inflammation. The study, which appears in the August ... compares the use of the Capsicum annum nasal spray ...
... (HealthDay News) -- Interbreeding between modern humans, Neanderthals and ... boost peoples, immune systems today, researchers report. Modern ... share a common African ancestor, the team of scientists ... Science . However, the groups diverged into separate, distinct ...
... hormone receptor guanylyl cyclase C (GCC) has been established ... evidence from Thomas Jefferson University suggests it ... pandemics: obesity. Reporting in the August 25 ... Scott Waldman, M.D., Ph.D., chairman of the ...
... , THURSDAY, Aug. 25 (HealthDay News) -- For kids, the end ... sleeping until noon: It also signals the beginning of brand new ... your child is a preschooler or a teen, some anxiety about ... is to know how to ease your children,s stress and manage ...
Cached Medicine News:Health News:Temporary ER staff poses increased safety risk to patients 2Health News:Temporary ER staff poses increased safety risk to patients 3Health News:Researchers developing new test to measure risk for birth defects and neuro-developmental disorders 2Health News:Thank Neanderthals for That Healthy Immune System, Scientists Say 2Health News:Could a tumor suppressor also fight obesity? 2Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3
(Date:9/2/2015)... Sept. 2, 2015  Kastle Therapeutics (Kastle), a ... pharmaceuticals for diseases with high unmet medical needs, ... to key commercial operating positions. ... Commercial; Sean was previously Global Marketing Director for ... as Director, Commercial Strategy and Analytics; Nick was ...
(Date:9/2/2015)... Research and Markets ... the "Pharmaceutical Regulatory Affairs in the Middle ... conference to their offering. An ... Particularly relevant for Pharmacovigilance, Regulatory Affairs, ... & Regulatory Authorities Topics to be ...
(Date:9/2/2015)... Sept. 2, 2015 The acute coronary syndrome ... drugs and hundreds of generics. While generic ACS drugs ... therapeutics is expected to increase to more than 60 ... and launch of novel pipeline products between 2015 and ... largest in terms of revenues, driven primarily by incidence ...
Breaking Medicine Technology:Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3Pharmaceutical Regulatory Affairs Course in the Middle East, Dubai (Dubai, UAE - October 18-19, 2015) 2Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 2Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 3
... Biopharma, Inc. (OTC Bulletin Board: GNBP ), ... has named Marvin S. Hausman M.D. as Chief Science Officer. ... care experience at various pharmaceutical companies. "We are ... Genesis Biopharma," said Anthony J. Cataldo, President and Chief Executive ...
... Rottenstein Law Group, which represents clients with claims stemming from ... by DePuy Orthopaedics, is fully in support of the FDA,s ... implants. At a new set of pages on ... Drug Administration states the following: FDA is actively ...
Cached Medicine Technology:Genesis Biopharma Names Marvin S. Hausman M.D. as Chief Science Officer 2Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall 2
... VerdaSee Mobile Location-ID™ offers a for asset ... are attached to all the assets that will ... device, is equipped with a reader, antenna, and ... be as small as 10 inches x 6 ...
... provides hospitals with a suite ... all their supplies, drugs, assets, ... remove all manual compliance from ... accurately. iRIS, or Intelligent Radio-Frequency ...
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
Medicine Products: